Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-22

Clinical Trial Update: Nitazoxanide in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nitazoxanide in patients with metastatic colorectal cancer is underway or planned; no results or status are provided yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN